Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ancient herbs put to the test: can a plant blend beat metformin for diabetes?

NCT ID NCT07279909

First seen Jan 05, 2026 · Last updated Jun 22, 2026 · Updated 22 times

Summary

This phase 3 trial tests a capsule made from four traditional anti-diabetic herbs (Syzygium cumini, bitter melon, Wrightia tinctoria, and Gymnema sylvestre) in 500 adults with type 2 diabetes. Participants take either the herbal capsule or the standard drug metformin three times daily for six months. The goal is to see if the herbal blend lowers blood sugar and HbA1c as effectively and safely as metformin.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES TYPE 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Mehboob Faryal Diagnostic Center

    Karachi, Sindh, 74700, Pakistan

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

a blend of four herbs (Syzygium cumini, bitter melon, Wrightia tinctoria, and Gymnema sylvestre) in a capsule

What this could lead to

If it works, this could offer a natural, plant-based option to help control blood sugar in type 2 diabetes, possibly with fewer side effects than standard drugs.

What could go wrong

This is a single study with 500 people, and herbal supplements can vary in potency. It may not prove better than metformin, and long-term safety is still unknown.

Conditions

The condition(s) this trial relates to.

Diabetes Mellitus, Experimental type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.